A membrane glycoprotein CD4 functions as a coreceptor of a T lymphocyte. The co-receptor function has been attributed to a protein tyrosine kinase, p56 lck , which is activated upon CD4 binding to MHC molecule. In this study, we present evidences that one of the pathways through which CD4 transmits its signal is cytoskeleton association of p56 lck tyrosine kinase as well as CD4 itself. Cytoskeletal association of both proteins is inhibited by a tyrosine kinase inhibitor, genistein, indicating that tyrosine protein kinase activation is important for cytoskeletal association of CD4 and p56 lck . Cytoskeletal association of these proteins by CD4 cross-linking is not affected by inhibitors of protein kinase C nor PI3-kinase. Taken together, these results suggest that CD4 cross-linking activates a tyrosine kinase which then induces the simultaneous association of CD4 and p56 lck with cytoskeleton.
Introduction
The CD4 molecule is a 55 kD membrane glycoprotein expressed on a subset of T cells, macrophages, and astrocytes. In T cells, CD4 exerts its signal by association with a TCR, when it recognizes the same MHC molecule as TCR. When a CD4 and a TCR are engaged in the same antigen-MHC complex, the TCR mediated signals are enhanced by 30-300 folds compared to the ones initiated by TCR alone. This greatly reduces the density of ligands required for the T-cell activation (Janeway et al., 1989) . This co-receptor function of CD4 has been attributed to a PTK, p56 lck , which is associated with the cytoplasmic domain of CD4 and is activated upon CD4 aggregation (Veillette et al., 1988) .
CD4 can also induce independent signals. Many studies have revealed that CD4 cross-linking with anti-CD4 antibodies prior to TCR engagement generates negative signals which inhibit proper T cell activation induced by TCR as well as by mitogens (Bank and Chess, 1985; Haughn et al., 1992; Racioppi et al., 1996) . It has been shown that HIV binding to CD4 generates similar negative signals which might cause T cell depletion during the pathogenesis of AIDS (Kornfeld et al., 1988; Banda et al., 1992) . The negative signal is likely due to the sequestration of p56 lck by CD4 cross-linking (Goldman et al., 1997) . Such sequestration may interfere with the TCR signaling by uncoupling lck signals from some critical substrates involved in the full activating process. CD4 cross-linking is shown to generate different patterns of tyrosine phosphorylation from CD3 or CD3-CD4 cocrosslinking (Thompson et al., 1992; Hubert et al., 1995; Goldman et al., 1997) .
Many T cell surface molecules such as CD2, CD3, CD4, CD8, CD11a/CD18, CD44, and class I MHC molecules can be induced to associate with detergent-insoluble cytoskeletal fraction (Marano et al., 1989; Geppert and Lipsky, 1991; Offringa and Bierer, 1993) . Recently, it has been shown that the engagement of CD28 and LFA-1 with their ligands triggers an active accumulation of these molecules at the interface of the T cell and antigenpresenting cell, during T cell activation. This movement appears to depend on myosin motor proteins which then increase the overall amplitude and duration of T cell signaling (Wulfing and Davis, 1998) . However, the signals, which mediate cytoskeletal associations of these molecules, have not been elucidated.
The surface CD4 is not associated with cytoskeleton in normal unstimulated condition (Geppert and Lipsky, 1991) . Upon cross-linking, its surface expression is down modulated and it becomes associated with cytoskeleton. Since CD4 exerts its function through p56 lck , we have examined whether p56 lck is associated with cytoskeleton and what mediates such association. We found that upon CD4 cross-linking, both p56 lck and CD4 were associated with cytoskeleton. Cytoskeletal association of both proteins is inhibited by a tyrosine kinase inhibitor, genistein, indicating that tyrosine protein kinase activation is important for cytoskeletal association of CD4 and p56 lck . Cytoskeletal association of CD4 and p56 lck induced by CD4 cross-linking is not affected by inhibitors of protein kinase C nor PI3-kinase. Taken together, these results suggest that CD4 cross-linking activates a tyrosine kinase which then induces the simultaneous association of CD4 and p56 lck with cytoskeleton.
Materials and Methods

Cells, reagents and antibodies
The 
Analysis of cell surface expression and cytoskeletal association of CD4 by FACS
For an analysis of the cell surface expression of CD4, CEM-T4 cells were incubated with a saturating concentration (10 µg/ml) of FITC conjugated anti-CD4 antibody at 4 o C for 30 min. Cells were washed 3 times with icecold RPMI 1640 media and CD4 molecules were crosslinked by incubation with 10 µg/ml goat anti-mouse antibody for 15 min at 4 o C. Basal levels of the surface CD4 expression were determined by flow cytometry without cross-linking. A total of 10,000 events were acquired for an each sample on FACScan (Becton Dickinson). For the analysis of cytoskeleton associated CD4, cells were incubated with FITC conjugated anti-CD4 antibody, with or without cross-linking by GAM and were treated with a lysis buffer containing 0.5% Triton X-100 for 30 min. The CD4 molecules that were not associated with cytoskeleton were solublized in Triton lysis buffer and removed. CD4 molecules associated with detergentinsoluble fractions were analyzed with flow cytometry.
Cell lysis and separation of detergent-soluble and -insoluble fractions
CEM-T4 cells were incubated in serum-free RPMI media at 37 o C for 4 h. All of kinase inhibitors; genistein (300 M), staurosporin (100 nM) and wortmannin (100 µM) were added 30 min prior to CD4 cross-linking or PMA (100 ng/ml) treatment. Cells were harvested and resuspended in ice-cold RPMI at 1 × 10 7 cells/ml. An anti-CD4 antibody (OKT4) were added at the concentration of 10 µg/ml and incubated for 1 h at 4 o C. CD4 molecules were cross-linked by incubation with 20 µg/ml goat anti-mouse antibody (GAM) for 15 min at 4 o C. Various times after incubation at 37 o C, cells were quickly chilled and lysed by the Triton-lysis buffer (0.5% Triton X-100, 1 mM Na 3 VO 4 , 50 mM NaF, 2 mM aprotinin, 2 mM leupeptin, 1 mM PMSF, 20 mM Tris, pH 7.4, 120 mM NaCl). The lysates were centrifuged for 15 min at 10,000 × g at 4 o C. The detergent-soluble fractions were analyzed by SDS-PAGE. The detergent-insoluble fractions were resuspended in SDS-PAGE sample buffer, boiled for 5 min and centrifuged at 15,000 × g for 30 min. The supernatants were analyzed prior to an analysis by SDS-PAGE.
Western analysis
Proteins were separated by 10% SDS-PAGE and electrophoretically transferred to a nitrocellulose membrane. CD4, p56 lck and tyrosine-phosphorylated proteins were detected by immunoblotting with anti-CD4 antibody, p56 lck antibody or anti-phosphotyrosine mAb respectively followed by incubation with HRP-conjugated secondary antibodies and ECL reaction (Amersham kit).
Results
CD4 cross-linking induces cytoskeletal association of p56 lck
It has been previously shown that CD4 cross-linking induces down-modulation of the surface CD4 expression as well as the cytoskeletal association of CD4 molecules. Since CD4 is associated with p56 lck by its cytoplasmic domain, we have examined a possible interaction of p56 lck with the cytoskeletal fraction upon CD4 cross-linking.
For this examination, surface CD4 molecules were cross-linked with monoclonal anti-CD4 antibody, OKT4, and goat anti-immunoglubulin antibody (GAM). At different times following the cross-linking, the Triton X-100-soluble cytosol or membrane fractions and Triton-insoluble cytoskeleton fractions were separated and analyzed by immunoblotting.
In a control where cells were treated with GAM alone ( Figure 1A and B, lanes 1-4), CD4 and p56 lck were present mainly in the cytosol fraction. Upon CD4 cross-linking (Figure 1: lanes 5-8) , both CD4 and p56 lck were partitioned into the cytoskeletal fraction. Such partitioning occurred even on ice during cross-linking. We were able to detect an immediate loss of p56 lck and CD4 from soluble fraction (Figure 1: lanes 5) . Cytoskeletal association of CD4 and p56 lck did not occur when cells were treated with OKT4 alone without cross-linking (Figure 1:  lanes 9-12) .
When the same membranes were analyzed with antiphosphotyrosine antibody (α-p-tyr), the tyrosine phosphorylated proteins at 56 kD was detected only when CD4 was cross-linked ( Figure 1A and 1B, lanes 5-8) . The tyrosine phosphorylated p56 protein was detected in cytoskeletal fraction ( Figure 1B) , as well as in the cytosol fraction ( Figure 1A ) and its band was also detected with anti-p56 lck , indicating that it was most likely p56 lck . The above results showed that CD4 cross-linking activated tyrosine kinase and induced tyrosine-phosphorylation and cytoskeletal association of both p56 lck and CD4.
PMA stimulation down-modulates CD4 but does not induce cytoskeletal association of CD4 nor p56 lck
Since CD4 cross-linking induced down-modulation of CD4, it was possible that the cytoskeletal association is related to CD4 down-modulation. To test this, a PKC activator, PMA that is known to down-modulate surface CD4 expression, was employed. PMA induces down-modulation of CD4 by dissociation of p56 lck hence exposing endocytic recognition sequence of CD4 (Aiken et al., 1994) .
As shown in Figure 2A , the PMA down-modulated CD4 within 15 min and the CD4 down-modulation could be blocked by a PKC inhibitor, staurosporin. This result indicates that CD4 down-modulation is due to PKC activation by PMA. The western analysis of the cytosol fraction ( Figure 2B ), however, did not reveal reduction of either CD4 or p56 lck following PMA treatment. The amounts of both proteins in cytosol remained unchanged regardless to the PMA treatment, showing that down-modulation of CD4 is not necessarily required for cytoskeletal association of CD4 and p56 lck . CD4 down-modulation can also be induced by OKT4 treatment without cross-linking, however we have not observed cytoskeletal association of CD4 either by western analysis (Figure 1; lanes 9-12) or by FACS analysis (data not shown).
The cytoskeletal association of CD4 p56 lck following CD4 cross-linking is dependent on the PTK activity
In order to further define the mechanism of the cytoskeletal association of CD4 and p56 lck , inhibitors for different kinases were tested for the ability to inhibit cytoskeletal association. For this, cells were pretreated with various kinase inhibitors before CD4 cross-linking, and then the detergent-soluble fractions were analyzed.
When CD4 cross-linking was carried out in the presence of a PTK inhibitor, genistein, more p56 lck proteins were left in Triton-soluble fraction ( Figure 3A, top) . However, there was no increase in the amount of p56 lck in the detergent-soluble fraction when a PKC inhibitor, staurosporin (middle), or a PI3-kinase, wortmannin (bottom), were tested. These results suggest that cytoskeletal association induced by CD4 cross-linking requires PTK activation. The cytoskeletal association did not appear to be mediated by PKC or PI3-kinase activation. In the presence of genistein, tyrosine phosphorylation of the 56 kD protein was reduced comparable to the level of cytoskeleton associated p56 lck (data not shown), again supporting the idea that the substrate of PTK activated by CD4 cross-linking is p56 lck .
To confirm the inhibitory effect of genistein for the cytoskeletal association of CD4, the cytoskeletal association of CD4 was also analyzed by flowcytometry. CD4 molecules were labeled with FITC-conjugated anti-CD4 antibody and cross-linked by GAM for 15 min. CD4 molecules that were not associated with cytoskeleton were washed away by the Triton X-100 treatment and cytoskeleton associated CD4 was analyzed by FACS. As shown in Figure 3B , when CD4 molecules were cross-linked in the presence of genistein, the cytoskeleton associated CD4 was greatly reduced compared to CD4 cross-linking without genistein.
Discussion
Several studies revealed that association of cytoskeleton with surface molecules plays an important role to transmit the signals generated at the membrane to the cytoskeletal structure and therefore modulate cellular responses.
In this study, we demonstrated that CD4 cross-linking induced a simultaneous cytoskeletal association of both CD4 and CD4 associated tyrosine kinase p56 lck . Our result further showed that the association of both CD4 and p56 lck with cytoskeleton required tyrosine kinase activation, probably that of p56 lck . TCR ligation induces association of TCR and tyrosine phosphorylated TCR ζ with the detergent-insoluble cell fraction (Rozdzial et al., 1995; Marano et al., 1997; Rozdzial et al., 1998) . P56 lck has been implicated in CD3 ζ-chain phosphorylation and ζ-cytoskeletal binding (Rozdzial et al., 1998) .
CD4 is mainly known to function as a co-receptor of TCR. However CD4 can also transmit an independent signal. The interaction of CD4 and MHC class II molecules without TCR engagement appears to negatively regulate antigen-independent adhesion of T cells. The negative regulation of adherence can be blocked by wortmannin, a PI3-kinase inhibitor, indicating that PI3-kinase participates in the regulation of cytoskeleton structure. The antigen-independent adhesion of T cells also requires the tyrosine kinase activity of the p56 lck (Doyle and Strominger, 1987; Mazerolles et al., 1994; Kinch et al., 1994) . Based on these results, it was postulated that activation of PI3-kinase associated with p56 lck leads to a cytoskeleton organization unfavorable of maintaining adherence. Unlike the negative regulation of adherence by antigen independent interaction of CD4 and MHC class II molecules, the cytoskeletal association of p56 lck induced by CD4 cross-linking was not affected by a PI3-kinase inhibitor but affected by a PTK inhibitor. One likely explanation is that an intial CD4 and MHC class II interaction requires p56 lck activation which subsequently induces cytoskeletal association. p56 lck activation then regulates cytoskeletal organization unfavorable for further (A) CEM-T4 cells were treated with genistein, staurosporin, or wortmannin 30 min prior to CD4 cross-linking. At various times after cross-linking, the presence of p56 lck in detergent-soluble fraction (lanes 1, 2 and 3) and ininsoluble fraction (lanes 4, 5 and 6) were analyzed by western analysis. Lanes 1 and 4, 1 min; lanes 2 and 5, 3 min; lanes 3 and 6, 15 min after cross-linking. (B) The cytoskeleton associated CD4 was analyzed by FACS as described in Materials and Methods. Cells were pretreated with genistein (thick line) or without genistein (thin line) 30 min prior to cross-linking that was carried out with FITC conjugated anti-CD4 mAb and GAM. Antibody control is shown with dotted line.
adhesion.
It is not clear yet whether CD4 and p56 lck bind to the cytoskeleton independently or in a CD4-p56 lck complex form. The co-segregation of CD4 and p56 lck with cytoskeletal fraction and the slow dissociation of CD4 from p56 lck (Juszcaak et al., 1991) suggest that CD4 and p56 lck are still in complex form. Clearly there are many different pathways by which CD4 mediates different signals generated by different stimulations. CD4 cross-linking induces down modulation of CD4, but cytoskeletal association is clearly not related to CD4 down modulation process. PMA induces CD4 down-modulation without the cytoskeletal association of p56 lck or CD4. Our results shown here strongly suggest that one of the pathways through which CD4 transmits its signals is cytoskeletal association of CD4 and p56 lck .
